We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$45.6M
2
OKTA icon
Okta
OKTA
+$43.1M
3
ROKU icon
Roku
ROKU
+$38.5M
4
ENPH icon
Enphase Energy
ENPH
+$37.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$31.1M

Sector Composition

Rank Sector Weight
1 Technology 32.17%
2 Consumer Discretionary 24.08%
3 Healthcare 19.02%
4 Industrials 8.18%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPRK icon
251
GeoPark
GPRK
$745M
– –
-313,627
Closed -$4.05M
LYFT icon
252
Lyft
LYFT
$6.02B
– –
-21,185
Closed -$281K
PANW icon
253
Palo Alto Networks
PANW
$306B
– –
-81,522
Closed -$6.71M
RARE icon
254
Ultragenyx Pharmaceutical
RARE
$1.34B
– –
-5,048
Closed -$301K
RCKT icon
255
Rocket Pharmaceuticals
RCKT
$377M
– –
-29,659
Closed -$408K
SGHT icon
256
Sight Sciences
SGHT
$448M
– –
-49,527
Closed -$445K
TLSI icon
257
TriSalus Life Sciences
TLSI
$287M
– –
-172,864
Closed -$1.7M
TMUS icon
258
T-Mobile US
TMUS
$196B
– –
-45,079
Closed -$6.07M
VCYT icon
259
Veracyte
VCYT
$3.31B
– –
-12,247
Closed -$244K
YETI icon
260
Yeti Holdings
YETI
$2.94B
– –
-7,594
Closed -$329K
ZUO
261
DELISTED
Zuora, Inc.
ZUO
– –
-723,029
Closed -$6.47M
FRXB
262
DELISTED
Forest Road Acquisition Corp. II
FRXB
– –
-128,726
Closed -$1.26M
ONEM
263
DELISTED
1Life Healthcare
ONEM
– –
-2,982,257
Closed -$23.4M
USER
264
DELISTED
UserTesting, Inc.
USER
– –
-85,817
Closed -$431K
ASZ
265
DELISTED
Austerlitz Acquisition Corporation II
ASZ
– –
-222,568
Closed -$2.17M
AUS
266
DELISTED
Austerlitz Acquisition Corporation I
AUS
– –
-82,320
Closed -$803K
7 8 9 10
11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.